タモキシフェンと非悪性疾患の徴候

Exercise Interventions for Preserving Physical Function Among Cancer Survivors in Middle to Late Life.

The Journal of frailty & aging·2016

Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.

Cold Spring Harbor perspectives in medicine·2014

Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.

Lupus·2008

The inositol trisphosphate receptor antagonist 2-aminoethoxydiphenylborate (2-APB) blocks Ca2+ entry channels in human platelets: cautions for its use in studying Ca2+ influx.

Cell calcium·2001

Effect of preproTRH antisense on thyrotropin-releasing hormone synthesis and viability of cultured rat diencephalic neurons.

Endocrine·2001

MR imaging of pituitary adenomas after gamma knife stereotactic radiosurgery.

AJR. American journal of roentgenology·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Mystery Client Methodologies to Evaluate Abortion Care and Access: A Scoping Review.

Healthcare (Basel, Switzerland)·2026

A Case of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Refractory to Treatment With Combination Therapy of Corticosteroid, Tocilizumab, and Rituximab: A Case Report.

Cureus·2026

Insertion of Subdermal Hormonal Implant May Trigger Complex Regional Pain Syndrome: A Case Report.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2026

Diagnosis of chlamydial and gonococcal conjunctivitis: performance evaluation of a nucleic acid amplification test.

Microbiology spectrum·2026

Limited Availability of Short Tandem Repeat Genotype Testing in the United States for Diagnosis of Partial Hydatidiform Mole: A Dilemma for Practicing Precision Medicine.

The American journal of surgical pathology·2026

Intrauterine Pregnancy With a Correctly Positioned Levonorgestrel-Releasing Intrauterine System: A Case Report.

Cureus·2026

関連する実験動画

タモキシフェンと非悪性疾患の徴候

関連する概念動画

Exercise Interventions for Preserving Physical Function Among Cancer Survivors in Middle to Late Life.

Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.

Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.

The inositol trisphosphate receptor antagonist 2-aminoethoxydiphenylborate (2-APB) blocks Ca2+ entry channels in human platelets: cautions for its use in studying Ca2+ influx.

Effect of preproTRH antisense on thyrotropin-releasing hormone synthesis and viability of cultured rat diencephalic neurons.

MR imaging of pituitary adenomas after gamma knife stereotactic radiosurgery.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Mystery Client Methodologies to Evaluate Abortion Care and Access: A Scoping Review.

A Case of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Refractory to Treatment With Combination Therapy of Corticosteroid, Tocilizumab, and Rituximab: A Case Report.

Insertion of Subdermal Hormonal Implant May Trigger Complex Regional Pain Syndrome: A Case Report.

Diagnosis of chlamydial and gonococcal conjunctivitis: performance evaluation of a nucleic acid amplification test.

Limited Availability of Short Tandem Repeat Genotype Testing in the United States for Diagnosis of Partial Hydatidiform Mole: A Dilemma for Practicing Precision Medicine.

Intrauterine Pregnancy With a Correctly Positioned Levonorgestrel-Releasing Intrauterine System: A Case Report.

関連する実験動画

タモキシフェンと非悪性疾患の徴候

関連する概念動画

関連記事